Alithea Genomics at ACT 2026

Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website

Alithea Genomics takes part in 1 session at ACT 2026 in San Antonio, and exhibits at Booth 705. Its program centres on DRUG-seq, ultra-high-throughput gene expression profiling used to sort compounds early and flag safety liabilities.

OrganizationACT 2026 Attendance
Alithea Genomics
Lausanne, Switzerland
Reagent and assay suppliers
Swiss company selling high-throughput RNA sequencing kits and services, such as DRUG-seq, for compound screening and studying toxicity mechanisms.
Booth
Exhibiting at Booth 705
Mon, Nov 169:30am–6:30pmTue, Nov 178:00am–4:30pm

Explore the full ACT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Antonio. Leave your work email and we’ll be in touch.

Privacy

Download the full ACT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Alithea Genomics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction